The nation of Zimbabwe has turned down a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years because of Washington's request for confidential information.
This move came to light after a official document dated December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official spokesman has since explained that the United States was demanding access to genetic material for scientific study and profit while was not willing to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued negotiations to find a deal agreeable to both sides so the nation's critical HIV treatment initiative can continue.
Wider Implications
This rejection follows a similar case in Kenya, where a court suspended a related deal with the US after concerns were filed about the security of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and accountability.
Based on reports, 16 African countries have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"In essence, our nation would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our population should a future health crisis arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks already established through the global health agency.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how future collaboration could be arranged in a way that respects the sovereignty and dignity of each country."
Medical Community Response
Medical experts stated it recognised the official position, but urged that negotiations should continue considering a large portion of the country's Aids initiatives depended on international support.
"Where technical issues arise, such as those involving information security or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," it added.
The halted deal highlights the continuing debate between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.